| Literature DB >> 32084249 |
Valentina Gentili1, Daria Bortolotti1, Mascia Benedusi2, Andrea Alogna1, Anna Fantinati1, Anna Guiotto2, Giulia Turrin1, Carlo Cervellati2, Claudio Trapella1, Roberta Rizzo1, Giuseppe Valacchi2,3,4.
Abstract
Mucus form H. aspersa muller has been reported to have several therapeutic proprieties, such as antimicrobial activity, skin protection and wound repair. In this study, we have analyzed H. aspersa mucus (Helixcomplex) bio-adhesive efficacy and its defensive properties against the ozone (O3) (0.5 ppm for 2 hours) exposure in human keratinocytes and reconstructed human epidermis models. Cytotoxicity, tissue morphology and cytokine levels were determined. We confirmed HelixComplex regenerative and bio-adhesive properties, the latter possibly via the characteristic mucopolysaccharide composition. In addition, HelixComplex was able to protect from O3 exposure by preventing oxidative damage and the consequent pro-inflammatory response in both 2D and 3D models. Based on this study, it is possible to suggest HelixComplex as a potentially new protective technology against pollution induced skin damage.Entities:
Year: 2020 PMID: 32084249 PMCID: PMC7034816 DOI: 10.1371/journal.pone.0229613
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Quali-quantitative chemical and microbiological composition of HelixComplex.
| Specification | Values | Measure unit |
|---|---|---|
| Aspect | Clear | |
| Color | Yellow | |
| Smell | Odourless | |
| pH | 7.0 | |
| Density | 1.1 | |
| Dry residual | 3.2 | g/L |
| Yield% | 0.12 | |
| Minerals | 350 | mg/L |
| Heavy metals | Absent | |
| Proteins | 250 | mg/L |
| GAGs (sulfurated) | 90 | mg/L |
| GAGs (unsulfurated) | 80 | mg/L |
| Glycolic acid | <200 | mg/L |
| Allantoin | <20 | mg/L |
| Poliphenols | 80 | mg/L |
| Sugars | 0.027 | g/L |
| Collagen | 80 | mg/L |
| Gram + | 0 | CFU |
| Gram − | 0 | CFU |
| Fungi | 0 | CFU |
Sequences of forward and reverse primers used to amplify the cytokines.
| TARGET | FORWARD PRIMER | REVERSE PRIMER |
|---|---|---|
| IL-1 alpha | ||
| IL-1 beta | ||
| IL-6 | ||
| IL-8 | ||
| IL-10 | ||
| TNF-alpha |
Fig 1Evaluation of HelixComplex cytotoxicity.
Keratinocytes were exposed to increasing doses of HelixComplex (HC) for up to 72 hours and cell viability was examined by MTT colorimetric assay. A) Cell viability was calculated at 24, 48 and 72 hours as percentage with respect to the control untreated cultures (set to 100% for each cell line). DMSO was used as positive control of cell death. B) Cell number was monitored over time by Trypan Blue staining. C) Representative images taken by light microscopy of monolayers of keratinocytes untreated or treated with HelixComplex at 48 hours. Magnification 100X.
Fig 2Scratch-wound healing assay and bio-adhesivity.
A) scratch-wound healing assay, with representative images taken at the indicated time points post wounding; B) quantification of wound repair at 24 hours expressed as % of wound repair in comparison with the 0 hour time point (*p = 0.0003); C) Bio-adhesivity of HelixComplex on human keratinocytes assessed by a lectin-based assay.
Fig 3Effect of HelixComplex pretreatment in ozone induce tissue damage.
A) Cytotoxicity evaluation was performed by LDH quantification. (*p = 0.012); B) Tissue morphology was evaluated by H&E staining. Basal, spinous, granulous and cornified epidermal layers are represented. Magnification 40X; Nikon Microphot FXA microscope (Nikon Instruments); C) The ability of O3 to induce oxidative stress was evaluated by H2O2 levels in RHE exposed to O3 and pre-treated with HelixComplex. (*T0 p = 0.02; T24 p = 0.0013); D) 4-Hydroxynonenal (4-HNE) levels (*T24 p = 0.001).
Fig 4Induction of molecular signals by HelixComplex treatment on RHE model.
A) IL-1beta mRNAs levels (*p = 0.0011), B) IL-8 (*p<0.001) mRNAs levels, C) IL-6 (*p = 0.0024) mRNAs (left panel) and protein (right panel) D) IL-10 (*p<0.0001) mRNAs (left panel) and protein (right panel). IL-6 (*p<0.001) and IL-10 (*p<0.0001) protein levels were determined by ELISA assay.